# FDA Inspection 1069221 - Redicare LLC - October 19, 2018

Source: https://www.keypedia.com/records/fda_inspections/redicare-llc/edb0f7be-20eb-4452-a630-92e4a754033b
Source feed: FDA_Inspections

> FDA Inspection 1069221 for Redicare LLC on October 19, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069221
- Company Name: Redicare LLC
- Inspection Date: 2018-10-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1258134 - 2025-01-10](https://www.keypedia.com/records/fda_inspections/redicare-llc/6ab2c4f5-20e6-457b-a937-851dc7e91ffa)
- [FDA Inspection 1258134 - 2025-01-10](https://www.keypedia.com/records/fda_inspections/redicare-llc/11753d7c-837b-47dd-8279-0d69be43ba03)
- [FDA Inspection 1258134 - 2025-01-10](https://www.keypedia.com/records/fda_inspections/redicare-llc/9f22727e-4bea-4add-92f4-3bf0e9fc101c)
- [FDA Inspection 1258134 - 2025-01-10](https://www.keypedia.com/records/fda_inspections/redicare-llc/ea2e6a4e-5b63-489e-8692-9f0b132991cf)
- [FDA Inspection 1166194 - 2022-03-25](https://www.keypedia.com/records/fda_inspections/redicare-llc/4a9633a8-e470-4069-9138-446bee3409d4)

Company: https://www.keypedia.com/companies/redicare-llc/65c7593c-6b75-49c8-ab6b-4008ec78f70f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c